Position changes disclosed in SEC Form 13F filings. These report a quarterly snapshot, not exact trade dates.
| Fund | Change | Quarter |
|---|---|---|
| Sanofi | Sanofi opened a new position worth $36,124,586. | 2026-06-30 |
| Redmile Group, LLC | Redmile Group, LLC increased this position by 2065% ($1,639,063 -> $35,486,359). | 2026-06-30 |
| EQT Fund Management S.a r.l. | EQT Fund Management S.a r.l. increased this position by 24% ($53,939,496 -> $66,743,056). | 2026-06-30 |
| Nantahala Capital Management, LLC | Nantahala Capital Management, LLC increased this position by 58% ($12,852,000 -> $20,355,080). | 2026-06-30 |
| Cormorant Asset Management, LP | Cormorant Asset Management, LP increased this position by 24% ($25,861,501 -> $32,000,217). | 2026-06-30 |
| TCG Crossover Management, LLC | TCG Crossover Management, LLC increased this position by 24% ($21,538,414 -> $26,650,964). | 2026-06-30 |
| FEDERATED HERMES, INC. | FEDERATED HERMES, INC. increased this position by 24% ($16,972,820 -> $21,001,640). | 2026-06-30 |
| Casdin Capital, LLC | Casdin Capital, LLC increased this position by 24% ($16,259,500 -> $20,119,000). | 2026-06-30 |
Largest reported positions as of 2026-06-30.
| Fund | Value | Shares |
|---|---|---|
| EQT Fund Management S.a r.l. | $66,743,056 | 5,141,992 |
| Sanofi | $36,124,586 | 2,783,096 |
| Redmile Group, LLC | $35,486,359 | 2,733,926 |
| Cormorant Asset Management, LP | $32,000,217 | 2,465,348 |
| TCG Crossover Management, LLC | $26,650,964 | 2,053,233 |
| FEDERATED HERMES, INC. | $21,001,640 | 1,618,000 |
| Nantahala Capital Management, LLC | $20,355,080 | 1,568,188 |
| Casdin Capital, LLC | $20,119,000 | 1,550,000 |
| Aberdeen Group plc | $10,990,101 | 846,695 |
| FMR LLC | $10,222,178 | 787,533 |
Data compiled from public SEC filings. This is informational reporting, not investment advice.
This page tracks Sanofi’s institutional portfolio activity as disclosed in its quarterly Form 13F filings with the SEC. Rather than a one-off news snapshot, think of it as a running ledger — new positions, exits, and size changes get logged here every quarter so you can see how the company’s biotech and pharma stakes shift … Read more